Peking Union Medical College Hospital: Pheochromocytoma trials

The registry lists 11 Pheochromocytoma studies with Peking Union Medical College Hospital as lead sponsor. 6 are open to participants now and 0 have results posted.

Early Phase 1 1Phase 2 5No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Prospective Cohort Study of Pheochromocytoma/ParagangliomaNot yet recruitingNCT07516275
• Al18F-NOTA-LM3 PET/CT in Patients With Pheochromocytoma and ParagangliomaRecruitingNCT07288931Not applicable
• The Efficacy and Safety of Penpulimab in the Treatment of Metastatic PPGL Patients Who Fail to Other Systemic TreatmentRecruitingNCT05885399Phase 2
• A Study on the Safety and Effectiveness of Temozolomide for Neoadjuvant Treatment of PPGLRecruitingNCT05885386Phase 2
• Prediction of Myocardial Injury After Laparoscopic Pheochromocytoma/ParaGangLioma ResectionRecruitingNCT05752773
• 18F-MFBG PET/CT in the Evaluation of Neural Crest TumorRecruitingNCT05069220Early Phase 1
• Correlation Between Preoperative Images of PPGL and Intraoperative HemodynamicsCompletedNCT06669481
• Prediction and Evaluation of Anlotinib Treatment Response Using Contrast Enhanced Ultrasound PPGL PatientsStatus unknownNCT06015061
• A Study on the Safety and Effectiveness of Anlotinib for Neoadjuvant Treatment of PPGLStatus unknownNCT05883085Phase 2
• The Efficacy and Safety of Temozolomide in Patients With MPPGLCompletedNCT05858177Phase 2
• The Efficacy and Safety of Anlotinib in Patients With Metastatic Pheochromocytoma or ParagangliomaCompletedNCT04860700Phase 2